Olfactory neuroblastoma

Abstract

Originating from the olfactory neuroepithelium, olfactory neuroblastoma is a rare malignant tumor of the nasal cavity that typically affects adults between the ages of 35 and 70. Clinical presentation predominantly consists of nonspecific symptoms such as nasal obstruction, nasal drainage or epistaxis, thus illustrating the need for a thorough diagnostic workup. In addition to a complete head and neck examination, rigid nasal endoscopy, biopsy and imaging are necessary to establish a definitive diagnosis as well as plan for treatment. Computed tomography (CT) and magnetic resonance imaging (MRI) are the primary imaging modalities utilized to assess for bony invasion and soft tissue involvement, respectively. Hyams grading system provides a histologic assessment of disease severity while various staging systems correlate severity of disease to anatomic location/progression. Treatment relies on both surgical intervention and radiation. In addition, ongoing research trials are investigating therapeutic targets. Given the risk of recurrence, extended post-treatment surveillance remains necessary.

Keywords

Olfactory neuroblastoma / esthesioneuroblastoma / sinonasal tumors / malignancy endoscopic sinus surgery / radiation therapy

References

[1] Berger L.L’sesthesion Euriepitheliome olfactif (Olfactory neuroblastoma).Bull Assoc Fr Etud Cancer1924;13:410-20Available from: https://api.semanticscholar.org/CorpusID:73936422. [Last accessed on 31 Oct 2024]

[2] Ferlito A,Rhys-Evans PH.Contemporary clinical commentary: esthesioneuroblastoma: an update on management of the neck.Laryngoscope2003;113:1935-8

[3] Broich G,Ottaviani F.Esthesioneuroblastoma: a general review of the cases published since the discovery of the tumour in 1924.Anticancer Res1997;17:2683-706

[4] Dulguerov P,Calcaterra TC.Esthesioneuroblastoma: a meta-analysis and review.Lancet Oncol2001;2:683-90

[5] Svane-Knudsen V,Hansen O,Marker P.Cancer of the nasal cavity and paranasal sinuses: a series of 115 patients.Rhinology1998;36:12-4

[6] Kuan EC,Carey RM.A population-based analysis of nodal metastases in esthesioneuroblastomas of the sinonasal tract.Laryngoscope2019;129:1025-9

[7] Kadish S,Wang CC.Olfactory neuroblastoma. A clinical analysis of 17 cases.Cancer1976;37:1571-6

[8] Dulguerov P.Esthesioneuroblastoma: the UCLA experience 1970-1990.Laryngoscope1992;102:843-9

[9] Rimmer J,Beale T,Howard D.Olfactory neuroblastoma: a 35-year experience and suggested follow-up protocol.Laryngoscope2014;124:1542-9

[10] Czapiewski P,Haybaeck J.Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment.Oncotarget2016;7:52584-96 PMCID:PMC5239575

[11] Nichols AC,Curry WT,Deschler DG.Esthesioneuroblastoma: the massachusetts eye and ear infirmary and massachusetts general hospital experience with craniofacial resection, proton beam radiation, and chemotherapy.Skull Base2008;18:327-37 PMCID:PMC2637063

[12] Oskouian RJ Jr,Dumont AS,Laurent JJ.Esthesioneuroblastoma: clinical presentation, radiological, and pathological features, treatment, review of the literature, and the University of Virginia experience.Neurosurg Focus2002;12:e4

[13] Wu K,Bhuyan R.Orbital invasion by Esthesioneuroblastoma: a comparative case series and review of literature.Orbit2022;41:1-14

[14] Ow TJ,Kupferman ME,Hanna EY.Esthesioneuroblastoma.Neurosurg Clin N Am2013;24:51-65

[15] Thompson LD.Olfactory neuroblastoma.Head Neck Pathol2009;3:252-9 PMCID:PMC2811627

[16] Touihmi S,Rkain I.An atypical Esthesioneuroblastoma of the sphenoid sinus: a case report.Ann Med Surg2023;85:2029-33 PMCID:PMC10205378

[17] Zhong W,Ye W.Primary olfactory neuroblastoma of the nasopharynx: a case report.Ear Nose Throat J2023;102:NP19-23

[18] Kumaria A,Paine S,Ingale HA.Olfactory neuroblastoma limited to sphenoid sinus.Br J Neurosurg2023;37:237-40

[19] Ward PD,Thompson BG.Esthesioneuroblastoma: results and outcomes of a single institution’s experience.Skull Base2009;19:133-40 PMCID:PMC2671304

[20] Koo BK,Jeon KH.Two cases of ectopic adrenocorticotropic hormone syndrome with olfactory neuroblastoma and literature review.Endocr J2008;55:469-75

[21] Sharma S,Walsh D.Paraneoplastic refractory hypercalcemia due to advanced metastatic esthesioneuroblastoma.Rhinology2008;46:153-5

[22] Gabbay U,Marshak G,Fliss DM.A case and a series of published cases of esthesioneuroblastoma (ENB) in which long-standing paraneoplastic SIADH had preceded ENB diagnosis.Ear Nose Throat J2013;92:E6

[23] Kunc M,Czapiewski P.Paraneoplastic syndromes in olfactory neuroblastoma.Contemp Oncol2015;19:6-16 PMCID:PMC4507891

[24] von Zeidler SV,Alencar Rde C.Atypical esthesioneuroblastoma invading oral cavity: a case report and review of the literature.Diagn Pathol2014;9:10 PMCID:PMC3943513

[25] Banuchi VE,Lee NY.Patterns of regional and distant metastasis in esthesioneuroblastoma.Laryngoscope2016;126:1556-61 PMCID:PMC4914404

[26] Zanation AM,Rinaldo A.When, how and why to treat the neck in patients with esthesioneuroblastoma: a review.Eur Arch Otorhinolaryngol2010;267:1667-71 PMCID:PMC3005584

[27] Fiani B,Cathel A.Esthesioneuroblastoma: a comprehensive review of diagnosis, management, and current treatment options.World Neurosurg2019;126:194-211

[28] Roytman M,Kacker A.[68Ga]-DOTATATE PET/CT and PET/MRI in the diagnosis and management of esthesioneuroblastoma: illustrative cases.J Neurosurg Case Lessons2021;1:CASE2058 PMCID:PMC9241319

[29] Chadha S.Esthesioneuroblastoma a case report.Indian J Otolaryngol Head Neck Surg2011;63:44-6

[30] Mozaffari K,Yang I,Vivas AC.Metastatic esthesioneuroblastoma recurrence after 19 years of remission: a systematic review with case illustration.J Neurol Sci2022;442:120406

[31] Pickuth D.Imaging of recurrent esthesioneuroblastoma.Br J Radiol1999;72:1052-7

[32] Dublin AB.Imaging characteristics of olfactory neuroblastoma (Esthesioneuroblastoma).J Neurol Surg B Skull Base2016;77:1-5 PMCID:PMC4777621

[33] Rostomily RC,Deng M.Clinical utility of somatostatin receptor scintigraphic imaging (octreoscan) in esthesioneuroblastoma: a case study and survey of somatostatin receptor subtype expression.Head Neck2006;28:305-12

[34] Vuncannon JR.Hemostasis in endoscopic sinus and skull base surgery.Curr Opin Otolaryngol Head Neck Surg2023;31:33-8

[35] Ali MF.Transcranial Doppler ultrasonography (uses, limitations, and potentials): a review article.Egypt J Neurosurg2021;36:114

[36] Dixon L,Grech-Sollars M,Camp S.Intraoperative ultrasound in brain tumor surgery: a review and implementation guide.Neurosurg Rev2022;45:2503-15 PMCID:PMC9349149

[37] Prada F,Casali C.Intraoperative navigated angiosonography for skull base tumor surgery.World Neurosurg2015;84:1699-707

[38] Tang H,Xie L.Intraoperative ultrasound assistance in resection of intracranial meningiomas.Chin J Cancer Res2013;25:339-45 PMCID:PMC3696709

[39] Jarmula J,Kshettry VR.The current state of visualization techniques in endoscopic skull base surgery.Brain Sci2022;12:1337 PMCID:PMC9599272

[40] AlQahtani A,Nicolai P,Locatelli D.Injury of the internal carotid artery during endoscopic skull base surgery: prevention and management protocol.Otolaryngol Clin North Am2016;49:237-52

[41] Josephson CB,Krishan A.Computed tomography angiography or magnetic resonance angiography for detection of intracranial vascular malformations in patients with intracerebral haemorrhage.Cochrane Database Syst Rev2014;2014:CD009372 PMCID:PMC6544803

[42] Raabe A,Gerlach R,Seifert V.Near-infrared indocyanine green video angiography: a new method for intraoperative assessment of vascular flow.Neurosurgery2003;52:132-9; discussion 139

[43] Suero Molina E, Bruneau M, Reuter G, et al; EANS Skull Base Section. Fluorescence guidance in skull base surgery: applications and limitations - A systematic review. Brain Spine 2024;4:103328. PMCID:PMC11416557

[44] Shahein M,Beaumont TL.The role of indocyanine green fluorescence in endoscopic endonasal skull base surgery and its imaging correlations.J Neurosurg2021;135:923-33

[45] Faragalla H.Olfactory neuroblastoma: a review and update.Adv Anat Pathol2009;16:322-31

[46] Mete O.Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: overview of the 2022 WHO Classification of Head and Neck Neuroendocrine Neoplasms.Head Neck Pathol2022;16:123-42 PMCID:PMC9018952

[47] Mehta GU,Su SY,DeMonte F.Management of olfactory neuroblastoma, neuroendocrine carcinoma, and sinonasal undifferentiated carcinoma involving the skullbase.J Neurooncol2020;150:367-75

[48] Bell D,Roberts D.Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes.Head Neck Pathol2015;9:51-9 PMCID:PMC4382491

[49] Ziai H,Weinreb I.Regional recurrences and Hyams grade in esthesioneuroblastoma.J Neurol Surg B Skull Base2021;82:608-14 PMCID:PMC8563269

[50] Morita A,Olsen KD,Lewis JE.Esthesioneuroblastoma: prognosis and management.Neurosurgery1993;32:706-14; discussion 714-5

[51] Girod D,Marentette L.Esthesioneuroblastoma.Head Neck2001;23:500-5

[52] Finlay JB,Jang DW,Goldstein BJ.Deconstructing olfactory epithelium developmental pathways in olfactory neuroblastoma.Cancer Res Commun2023;3:980-90 PMCID:PMC10243222

[53] Lechner M,Turri-Zanoni M.Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma.Eur J Cancer2022;162:221-36 PMCID:PMC9554673

[54] Walch C,Anderhuber W,Köle W.The minimally invasive approach to olfactory neuroblastoma: combined endoscopic and stereotactic treatment.Laryngoscope2000;110:635-40

[55] Shah JP,Bilsky MH,Harrison LH.Craniofacial resection for malignant tumors involving the anterior skull base.Arch Otolaryngol Head Neck Surg1997;123:1312-7

[56] Levine PA,Cantrell RW.Esthesioneuroblastoma: reflections of a 21-year experience.Laryngoscope1999;109:1539-43

[57] Kuan EC,Adappa ND.International consensus statement on allergy and rhinology: sinonasal tumors.Int Forum Allergy Rhinol2024;14:149-608

[58] Wang EW,Gardner PA.ICAR: endoscopic skull-base surgery.Int Forum Allergy Rhinol2019;9:S145-365

[59] Unger F,Walch C,Papaefthymiou G.Combined endoscopic surgery and radiosurgery as treatment modality for olfactory neuroblastoma (esthesioneuroblastoma).Acta Neurochir2005;147:595-601; discussion 601

[60] Gallia GL,Salmasi V,Koch W.Endonasal endoscopic resection of esthesioneuroblastoma: the Johns Hopkins Hospital experience and review of the literature.Neurosurg Rev2011;34:465-75

[61] Lund V,Wei WI.Endoscopic resection of malignant tumors of the nose and sinuses.Am J Rhinol2007;21:89-94

[62] Castelnuovo P,Delù G,Bignardi M.Endonasal endoscopic resection and radiotherapy in olfactory neuroblastoma: our experience.Head Neck2007;29:845-50

[63] Nicolai P,Bignami M.Endoscopic surgery for malignant tumors of the sinonasal tract and adjacent skull base: a 10-year experience.Am J Rhinol2008;22:308-16

[64] Suriano M,Colli A,Mascelli A.Endoscopic treatment of esthesioneuroblastoma: a minimally invasive approach combined with radiation therapy.Otolaryngol Head Neck Surg2007;136:104-7

[65] Folbe A,Duvvuri U.Endoscopic endonasal resection of esthesioneuroblastoma: a multicenter study.Am J Rhinol Allergy2009;23:91-4

[66] Fu TS,Muhanna N,de Almeida JR.Comparison of outcomes for open versus endoscopic approaches for olfactory neuroblastoma: a systematic review and individual participant data meta-analysis.Head Neck2016;38 Suppl 1:E2306-16

[67] Spielman DB,Grewal M.Exclusively endoscopic surgical resection of esthesioneuroblastoma: a systematic review.World J Otorhinolaryngol Head Neck Surg2022;8:66-72 PMCID:PMC9126163

[68] Hanna E,Ibrahim S,Levine N.Endoscopic resection of sinonasal cancers with and without craniotomy: oncologic results.Arch Otolaryngol Head Neck Surg2009;135:1219-24

[69] Komotar RJ,Raper DM,Schwartz TH.Endoscopic endonasal compared with anterior craniofacial and combined cranionasal resection of esthesioneuroblastomas.World Neurosurg2013;80:148-59

[70] Barinsky GL,Kilic S.Comparison of open and endoscopic approaches in the resection of esthesioneuroblastoma.Ann Otol Rhinol Laryngol2021;130:136-41

[71] Hannan CJ,Javadpour M.Methods of skull base repair following endoscopic endonasal tumor resection: a review.Front Oncol2020;10:1614 PMCID:PMC7431707

[72] Snyderman CH,Zenonos GA.Reconstruction after endoscopic surgery for skull base malignancies.J Neurooncol2020;150:463-8

[73] Adel M.Using a nasoseptal flap for the reconstruction of osteoradionecrosis in nasopharyngeal carcinoma: a case report.J Otolaryngol Head Neck Surg2016;45:27 PMCID:PMC4848806

[74] Harvey RJ,Sacks R.Endoscopic skull base reconstruction of large dural defects: a systematic review of published evidence.Laryngoscope2012;122:452-9

[75] Patel MR,Hackman TG.Beyond the nasoseptal flap: outcomes and pearls with secondary flaps in endoscopic endonasal skull base reconstruction.Laryngoscope2014;124:846-52

[76] Germani RM,Herzallah IR.Endoscopic reconstruction of large anterior skull base defects using acellular dermal allograft.Am J Rhinol2007;21:615-8

[77] de Almeida JR,Vaz Guimaraes Filho F.Comparison of endoscopic endonasal and bifrontal craniotomy approaches for olfactory groove meningiomas: a matched pair analysis of outcomes and frontal lobe changes on MRI.J Clin Neurosci2015;22:1733-41

[78] Stamm AC,Harvey RJ,Herman DR.Endoscopic transnasal craniotomy and the resection of craniopharyngioma.Laryngoscope2008;118:1142-8

[79] Abergel A,Margalit N,Gil Z.Comparison of quality of life after transnasal endoscopic vs open skull base tumor resection.Arch Otolaryngol Head Neck Surg2012;138:142-7

[80] de Almeida JR, Witterick IJ, Vescan AD. Functional outcomes for endoscopic and open skull base surgery: an evidence-based review.Otolaryngol Clin North Am2011;44:1185-200

[81] Eloy JA,Hoang K.Comparison of transnasal endoscopic and open craniofacial resection for malignant tumors of the anterior skull base.Laryngoscope2009;119:834-40

[82] Tajudeen BA,Suh JD,Wang MB.Importance of tumor grade in esthesioneuroblastoma survival: a population-based analysis.JAMA Otolaryngol Head Neck Surg2014;140:1124-9

[83] Jethanamest D,Sikora AG.Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors.Arch Otolaryngol Head Neck Surg2007;133:276-80

[84] Devaiah AK.Treatment of esthesioneuroblastoma: a 16-year meta-analysis of 361 patients.Laryngoscope2009;119:1412-6

[85] Benfari G,Ciofalo A.Radiotherapy alone for local tumour control in esthesioneuroblastoma.Acta Otorhinolaryngol Ital2008;28:292-7 PMCID:PMC2689543

[86] Gruber G,Baumert B,Raveh J.Esthesioneuroblastoma: irradiation alone and surgery alone are not enough.Int J Radiat Oncol Biol Phys2002;54:486-91

[87] Platek ME,Mashtare TL.Improved survival following surgery and radiation therapy for olfactory neuroblastoma: analysis of the SEER database.Radiat Oncol2011;6:41 PMCID:PMC3098784

[88] Schwartz JS,Adappa ND.Contemporary management of esthesioneuroblastoma.Curr Opin Otolaryngol Head Neck Surg2016;24:63-9

[89] Herr MW,Meier JC.Esthesioneuroblastoma: an update on the massachusetts eye and ear infirmary and massachusetts general hospital experience with craniofacial resection, proton beam radiation, and chemotherapy.J Neurol Surg B Skull Base2014;75:58-64 PMCID:PMC3912136

[90] Tajudeen BA,Suh JD.Esthesioneuroblastoma: an update on the UCLA experience, 2002-2013.J Neurol Surg B Skull Base2015;76:43-9 PMCID:PMC4318727

[91] Loy AH,Read PW.Esthesioneuroblastoma: continued follow-up of a single institution’s experience.Arch Otolaryngol Head Neck Surg2006;132:134-8

[92] Su SY,Ferrarotto R.Outcomes for olfactory neuroblastoma treated with induction chemotherapy.Head Neck2017;39:1671-9

[93] Porter AB,Giannini C.Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma.J Neurooncol2008;90:201-4

[94] Lucas JT Jr,MacDonald SM.Proton therapy for pediatric and adolescent esthesioneuroblastoma.Pediatr Blood Cancer2015;62:1523-8 PMCID:PMC9124545

[95] Eich HT,Micke O,Berthold F.Esthesioneuroblastoma in childhood and adolescence. Better prognosis with multimodal treatment?.Strahlenther Onkol2005;181:378-84

[96] Dumont B,Cordero C.Esthesioneuroblastoma in children, adolescents and young adults.Bull Cancer2020;107:934-45

[97] Howell MC,Snyderman CH.Patterns of regional spread for esthesioneuroblastoma.AJNR Am J Neuroradiol2011;32:929-33 PMCID:PMC7965541

[98] Noh OK,Yoon SM.Radiotherapy for esthesioneuroblastoma: is elective nodal irradiation warranted in the multimodality treatment approach?.Int J Radiat Oncol Biol Phys2011;79:443-9

[99] Monroe AT,Amdur RJ,Mendenhall WM.Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation.Head Neck2003;25:529-34

[100] Demiroz C,Aboziada M,Marentette LJ.Esthesioneuroblastoma: is there a need for elective neck treatment?.Int J Radiat Oncol Biol Phys2011;81:e255-61

[101] Argiris A,Tseke P.Esthesioneuroblastoma: the Northwestern University experience.Laryngoscope2003;113:155-60

[102] Gore MR.Salvage treatment of late neck metastasis in esthesioneuroblastoma: a meta-analysis.Arch Otolaryngol Head Neck Surg2009;135:1030-4

[103] Malouf GG,Deutsch E,Temam S.Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome.Eur J Cancer2013;49:1324-34

[104] Rinaldo A,Shaha AR,Lund VJ.Esthesioneuroblastoma and cervical lymph node metastases: clinical and therapeutic implications.Acta Otolaryngol2002;122:215-21

[105] Konuthula N,Miles B.Prognostic significance of Kadish staging in esthesioneuroblastoma: an analysis of the National Cancer Database.Head Neck2017;39:1962-8 PMCID:PMC5993196

[106] Stokes WA,Banglawala SM.Is sex an independent prognostic factor in esthesioneuroblastoma?.Am J Rhinol Allergy2015;29:369-72

[107] Bachar G,Shah M.Esthesioneuroblastoma: the princess margaret hospital experience.Head Neck2008;30:1607-14

[108] Diaz EM Jr,Pero C.Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center.Head Neck2005;27:138-49

[109] Broski SM,Johnson GB,Peller PJ.The added value of 18F-FDG PET/CT for evaluation of patients with esthesioneuroblastoma.J Nucl Med2012;53:1200-6

[110] Palmieri DE,Valappil B.DOTATATE PET imaging in olfactory neuroblastoma and association with SSTR expression.J Neurol Surg B Skull Base2024;85:439-44 PMCID:PMC11368451

[111] Dadgar H,Ahmadzadehfar H.68Ga-DOTATATE and 18F-FDG PET/CT for the management of esthesioneuroblastoma of the sphenoclival region.Clin Nucl Med2020;45:e363-4

[112] Classe M,Mouawad R.Integrated multi-omic analysis of esthesioneuroblastomas identifies two subgroups linked to cell ontogeny.Cell Rep2018;25:811-21.e5

[113] Zunitch MJ,Lin B.Molecular evidence for olfactory neuroblastoma as a tumor of malignant globose basal cells.Mod Pathol2023;36:100122 PMCID:PMC10198888

[114] Finlay JB,Hawgood SB.Olfactory neuroblastoma mimics molecular heterogeneity and lineage trajectories of small-cell lung cancer.Cancer Cell2024;42:1086-105.e13 PMCID:PMC11186085

[115] Hasan OK,Kong G.Efficacy of peptide receptor radionuclide therapy for esthesioneuroblastoma.J Nucl Med2020;61:1326-30

[116] London NR Jr,Bishop JA.Expression of programmed cell death ligand 1 and associated lymphocyte infiltration in olfactory neuroblastoma.World Neurosurg2020;135:e187-93

[117] Phase 2 study of bintrafusp alfa in recurrent/metastatic olfactory Neuroblastoma (BARON). Available from: https://classic.clinicaltrials.gov/show/NCT05012098. [Last accessed on 31 Oct 2024]